CORLINE BIOMEDICAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.4 SEK | -2.80% |
|
+1.96% | -30.20% |
| 04-30 | Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-14 | Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 21.81M | - | - | - | - | - | |
| 79.28B | ||||||
| 8.74B | ||||||
| 4.84B | ||||||
| 4.74B | - | - | ||||
| 3.87B |
